ATE445704T1 - Expressionsvektor für tierische zellen - Google Patents

Expressionsvektor für tierische zellen

Info

Publication number
ATE445704T1
ATE445704T1 AT01957013T AT01957013T ATE445704T1 AT E445704 T1 ATE445704 T1 AT E445704T1 AT 01957013 T AT01957013 T AT 01957013T AT 01957013 T AT01957013 T AT 01957013T AT E445704 T1 ATE445704 T1 AT E445704T1
Authority
AT
Austria
Prior art keywords
vector
expression vector
present
animal cells
expression
Prior art date
Application number
AT01957013T
Other languages
English (en)
Inventor
Jong-Mook Kim
Jung-Seob Kim
Sun-Mo Oh
Jae-Seung Yoon
Kwang-Hee Baek
Soo-Il Chung
Doo-Hong Park
Yeup Yoon
Original Assignee
Mogam Biotech Res Inst
Neurotech Pharmaceuticals Co L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mogam Biotech Res Inst, Neurotech Pharmaceuticals Co L filed Critical Mogam Biotech Res Inst
Application granted granted Critical
Publication of ATE445704T1 publication Critical patent/ATE445704T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717—Plasma globulins, lactoglobulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/595—Gastrins; Cholecystokinins [CCK]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT01957013T 2000-07-29 2001-07-27 Expressionsvektor für tierische zellen ATE445704T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0043996A KR100408844B1 (ko) 2000-07-29 2000-07-29 동물세포 발현벡터
PCT/KR2001/001285 WO2002014525A2 (en) 2000-07-29 2001-07-27 Expression vector using for animal cell

Publications (1)

Publication Number Publication Date
ATE445704T1 true ATE445704T1 (de) 2009-10-15

Family

ID=19680759

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01957013T ATE445704T1 (de) 2000-07-29 2001-07-27 Expressionsvektor für tierische zellen

Country Status (10)

Country Link
US (1) US7422874B2 (de)
EP (1) EP1392835B1 (de)
JP (1) JP4138479B2 (de)
KR (1) KR100408844B1 (de)
CN (1) CN1262663C (de)
AT (1) ATE445704T1 (de)
AU (1) AU2001278797A1 (de)
DE (1) DE60140218D1 (de)
ES (1) ES2333774T3 (de)
WO (1) WO2002014525A2 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1395669B1 (de) * 2001-01-26 2009-07-22 Selexis S.A. Matrix-anheftungsregionen und verfahren zu deren verwendung
NZ536475A (en) * 2002-05-24 2008-06-30 Schering Corp Neutralizing human anti-igfr antibody
AU2003263161A1 (en) * 2002-09-20 2004-04-08 Novo Nordisk A/S Method for making recombinant proteins
US6933136B2 (en) 2002-09-20 2005-08-23 Novo Nordisk A/S Method for making recombinant proteins
KR100755931B1 (ko) * 2003-06-11 2007-09-06 (주)두비엘 고분자형 만노스 결합형 렉틴의 대량 생산방법 및 상기방법으로 제조된 만노스 결합형 렉틴 재조합 단백질의제제화
US7135338B2 (en) * 2003-06-11 2006-11-14 Dobeel Corporation Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism
PL1959011T3 (pl) 2003-10-24 2012-07-31 Selexis Sa Wysokowydajny transfer genu i ekspresja w komórkach ssaczych przez procedurę wielokrotnej transfekcji sekwencji regionu przylegania do macierzy
ATE514783T1 (de) 2003-11-12 2011-07-15 Schering Corp Plasmidsystem zur expression mehrerer gene
PE20050928A1 (es) 2003-11-21 2005-11-08 Schering Corp Combinaciones terapeuticas de anticuerpo anti-igfr1
ES2360504T3 (es) * 2004-10-28 2011-06-06 Dobeel Co., Ltd. Método para la producción en masa de lectina multimérica de unión a manosa.
US8772021B2 (en) 2005-03-04 2014-07-08 Celltrion, Inc. Expression vector for animal cell comprising at least one copy of MAR DNA sequences at the 3′ terminal of transcription termination region of a gene and method for the expression of foreign gene using the vector
KR100779761B1 (ko) * 2005-10-28 2007-11-30 대한민국 인슐린 억제 및 사람 ｉｄｅ 유전자로 형질전환된 동물 및그 제조방법
KR100836745B1 (ko) * 2007-01-31 2008-06-10 (주)두비엘 Ｈｂｖ 백신 및 그의 제조 방법
WO2008153366A2 (en) 2007-06-15 2008-12-18 Mogam Biotechnology Research Institute Method for manufacturing active recombinant blood coagulation factor ix
CN101348786B (zh) * 2007-07-20 2011-05-11 谭孟群 一种人β珠蛋白基因及其重组腺相关病毒载体
US20110195451A1 (en) * 2008-06-10 2011-08-11 Isis Innovation Limited Protein Expression
KR101054362B1 (ko) 2008-07-03 2011-08-05 재단법인 목암생명공학연구소 재조합 단백질의 푸코스 함량을 감소시키는 방법
US8137933B2 (en) 2008-11-12 2012-03-20 Schering Corporation Mammalian expression vector pUHAB
US20120064631A1 (en) * 2009-03-27 2012-03-15 Hiroshima University Method for amplification and high-level expression of target gene in mammalian cell, and kit for achieving the method
CN102575264A (zh) * 2009-09-18 2012-07-11 瑟莱克斯公司 增加的转基因表达和加工的产品和方法
US20130034875A1 (en) * 2009-10-01 2013-02-07 Toto Ltd. Dna construct, and process for production of recombinant cho cell using same
US20120270264A1 (en) * 2009-10-01 2012-10-25 Toto Ltd. Dna construct, and process for production of recombinant cho cell using same
CA2813903A1 (en) 2010-10-08 2012-04-12 Cadila Healthcare Limited Expression vector for high level expression of recombinant proteins
ES2617217T3 (es) 2011-03-30 2017-06-15 Pangen Biotech Inc. Vector de expresión para células animales
JP5972866B2 (ja) 2011-03-31 2016-08-17 クニミネ工業株式会社 タンパク質結晶化条件探索剤及びタンパク質結晶化条件探索方法
KR101420274B1 (ko) * 2011-06-13 2014-07-21 주식회사 종근당 Ｃｓｐ－ｂ ５＇ｓａｒ 인자를 포함하는 동물세포 발현 벡터 및 이를 이용한 재조합 단백질의 제조방법
ES2806146T3 (es) 2011-09-22 2021-02-16 Amgen Inc Proteínas de unión al antígeno CD27L
HRP20200744T1 (hr) 2011-12-22 2020-07-24 F. Hoffmann - La Roche Ag Organizacija ekspresijskog vektora, novi postupci generiranja proizvodnje stanica i njihova uporaba za rekombinantnu proizvodnju polipeptida
RU2756910C2 (ru) * 2011-12-22 2021-10-06 Ф. Хоффманн-Ля Рош Аг Комбинации элементов экспрессионного вектора, новые способы получения клеток-продуцентов и их применение для рекомбинантного получения полипептидов
AR091069A1 (es) 2012-05-18 2014-12-30 Amgen Inc Proteinas de union a antigeno dirigidas contra el receptor st2
UY35148A (es) 2012-11-21 2014-05-30 Amgen Inc Immunoglobulinas heterodiméricas
US9546203B2 (en) 2013-03-14 2017-01-17 Amgen Inc. Aglycosylated Fc-containing polypeptides with cysteine substitutions
WO2014144817A2 (en) 2013-03-15 2014-09-18 Amgen Inc. Inhibitory polypeptides specific to wnt inhibitors
CN103194455B (zh) * 2013-04-08 2014-10-15 山东省农业科学院畜牧兽医研究所 高效表达的猪粒细胞巨噬细胞集落刺激因子基因及其表达蛋白的用途
SG11201508829QA (en) 2013-05-30 2015-12-30 Biogen Ma Inc Oncostatin m receptor antigen binding proteins
CA2923145C (en) 2013-09-05 2025-09-16 Amgen Inc. MOLECULES CONTAINING FCS AND EXHIBITING PREDICTABLE, UNIFORM AND REPRODUCIBLE GLYCOFORM PROFILES
KR102275504B1 (ko) * 2013-09-05 2021-07-09 사렙타 쎄러퓨틱스, 인코퍼레이티드 산성 알파-글루코시다제 내 안티센스-유도된 엑손2 포함
KR101591823B1 (ko) 2013-12-27 2016-02-04 재단법인 목암생명공학연구소 증가된 유전자 발현능을 갖는 발현벡터
MX2017012966A (es) 2015-04-10 2018-06-06 Amgen Inc Muteinas de interleuquina 2 para la expansion de celulas t regulatorias.
EP3286227A2 (de) 2015-04-24 2018-02-28 F. Hoffmann-La Roche AG Multispezifische antigenbindende proteine
AU2016329001A1 (en) 2015-09-22 2018-03-29 Genentech, Inc. Expression of Fc-containing proteins
WO2017059551A1 (en) 2015-10-08 2017-04-13 Zymeworks Inc. Antigen-binding polypeptide constructs comprising kappa and lambda light chains and uses thereof
WO2017079165A1 (en) 2015-11-02 2017-05-11 Genentech, Inc. Methods of making fucosylated and afucosylated forms of a protein
MY200252A (en) 2016-04-18 2023-12-16 Sarepta Therapeutics Inc Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
CN115073581A (zh) 2016-05-04 2022-09-20 美国安进公司 用于扩增t调节性细胞的白细胞介素-2突变蛋白
WO2018150345A1 (en) * 2017-02-16 2018-08-23 De Vita Bio Life Sciences An expression vector
RU2019142330A (ru) 2017-06-30 2021-07-30 Займворкс, Инк. Стабилизированные химерные fab
CN110343718A (zh) * 2018-04-03 2019-10-18 新乡医学院 一种高效稳定的细胞表达载体、表达系统及其制备方法、应用
UY38836A (es) 2019-08-13 2021-02-26 Amgen Inc Muteínas de interleucina-2 para la expansión de células t reguladoras
CN114867749A (zh) 2019-12-17 2022-08-05 安进公司 用于疗法中的双重白介素-2/tnf受体激动剂
AU2024307352A1 (en) 2023-06-27 2025-12-11 Amgen Inc. Charge pair mutations to enable correct heavy-light chain pairing
WO2025265034A1 (en) * 2024-06-20 2025-12-26 The Trustees Of The University Of Pennsylvania Transitory modulation of gene transcription through targeted mrna-lnp delivery of modified transcription activator-like effectors (tale)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956288A (en) * 1988-04-22 1990-09-11 Biogen, Inc. Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA
US5108901A (en) * 1988-09-02 1992-04-28 Genentech, Inc. Tissue plasminogen activator having zymogenic or fibrin specific properties
DE69331908T2 (de) 1992-10-05 2002-12-12 North Carolina State University, Raleigh Verfahren zur erhöhung der expression und zur verminderung der expressionsvariabilität von fremdgenen in pflanzenzellen
CA2159639A1 (en) * 1993-04-02 1994-10-13 Vincent J. Miles Method for selective inactivation of viral replication
US5773695A (en) 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
AU718551B2 (en) * 1996-06-06 2000-04-13 Novartis Ag Vectors comprising SAR elements
CA2257719C (en) 1996-06-11 2005-05-31 Wesley B. Bruce A synthetic plant core promoter and upstream regulatory element
US6245974B1 (en) 1997-08-06 2001-06-12 North Carolina State University Matrix attachment regions
KR100313559B1 (ko) 1998-07-22 2002-03-08 허영섭 수용성 TGFβ 수용체를 발현하는 재조합 세포주 및 전기세포주를 이용한 암치료 방법
US6388066B1 (en) * 1998-09-29 2002-05-14 Pioneer Hi-Bred International, Inc. MAR/SAR elements flanking RSYN7-driven construct
EP1395669B1 (de) * 2001-01-26 2009-07-22 Selexis S.A. Matrix-anheftungsregionen und verfahren zu deren verwendung

Also Published As

Publication number Publication date
EP1392835A4 (de) 2006-04-19
CN1262663C (zh) 2006-07-05
ES2333774T3 (es) 2010-03-01
WO2002014525A2 (en) 2002-02-21
DE60140218D1 (de) 2009-11-26
EP1392835B1 (de) 2009-10-14
KR100408844B1 (ko) 2003-12-06
US20040038394A1 (en) 2004-02-26
WO2002014525A3 (en) 2003-11-20
KR20020010327A (ko) 2002-02-04
JP4138479B2 (ja) 2008-08-27
AU2001278797A1 (en) 2002-02-25
EP1392835A2 (de) 2004-03-03
CN1444657A (zh) 2003-09-24
US7422874B2 (en) 2008-09-09
JP2004506428A (ja) 2004-03-04

Similar Documents

Publication Publication Date Title
DE60140218D1 (de) Expressionsvektor für tierische zellen
WO1999040197A3 (en) Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
EA200600525A1 (ru) Еро-имитирующие миметичекие антитела человека с центральной шарнирной областью, композиции, способы и применения
ATE440951T1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
NO20012718D0 (no) Ekspresjonssystem for faktor VIII
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
DE60041243D1 (de) Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins
ATE291586T1 (de) Humanes antibiotisches protein
ATE309270T1 (de) ßSMOOTHENEDß PROTEINE AUS WIRBELTIEREN
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
DE60126602D1 (de) Neue collectine
EA200401390A1 (ru) N-ацетилглюкозамин-6-фосфатдеацетилаза человека, взаимодействующая с каспазой-8, и способы ее применения
DK1287134T3 (da) Den humane spændings-gatede natriumkanal 1A-subunit og fremgangsmåder til anvendelse deraf
WO2001042287A3 (en) Putative human g-protein coupled receptors
TR199802300T2 (xx) �nsan G proteini �3 alt-birimindeki bir gendeki genetik d�n���m�n hastal�klar�n te�hisi i�in kullan�lmas�.
MY143222A (en) Expression vector for animal cell
ATE470716T1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
NO20023015L (no) Humant heparanasebeslektet polypeptid og nukleinsyre
WO2003082206A3 (en) Multiple sclerosis-related immunoglobulin derived proteins, compositions, methods and uses
DK0811068T3 (da) Humane DNase I varianter
ATE407944T1 (de) Mit trp-proteinen verwandtes protein mtr1 und dieses codierende dna-sequenz
EP1140968A4 (de) Dna-moleküle kodierende spleissvarianten des humanen melanocortin-1-rezeptorproteins
DE60137222D1 (de) Humanes trp-ähnliches kalziumkanalprotein-2 tlcc-2
ATE346926T1 (de) Menschliche twik-8 moleküle und ihre verwendung

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties